Gj. Marek et Gk. Aghajanian, LSD AND THE PHENETHYLAMINE HALLUCINOGEN DOI ARE POTENT PARTIAL AGONISTS AT 5-HT2A RECEPTORS ON INTERNEURONS IN RAT PIRIFORM CORTEX(1,2), The Journal of pharmacology and experimental therapeutics, 278(3), 1996, pp. 1373-1382
Correlations between 5-hydroxytryptamine (5-HT) receptor binding affin
ities and human hallucinogenic potency have suggested that 5-HT2 recep
tors mediate the hallucinogenic effects of lysergic acid diethylamide
(LSD) and phenethylamine hallucinogens. Electrophysiological studies h
ave suggested that a subpopulation of gamma-aminobutyric acid (GABA)er
gic interneurons in layer III of the rat piriform cortex are excited b
y serotonin (5-HT) via 5-HT2A receptors. These interneurons have inhib
itory inputs on pyramidal cells in layer II. In the present study, we
tested low concentrations of both LSD (3-100 nM) and the phenethylamin
e hallucinogen 1-(2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI; 0.3-
10 mu M) on rat piriform cortical interneurons that were excited by 5-
HT. Both LSD (3-100 nM) and DOI (0.3-10 mu M) excited almost every cel
l excited by 5-HT. The maximal excitation achieved with LSD and DOI wa
s 39% and 55% of the effect of a near-maximal 5-HT concentration (100
mu M). Consistent with a partial agonist action, LSD and DOI blocked t
he 5-HT excitation of piriform cortical interneurons only at the highe
r hallucinogen concentrations tested. A specific 5-HT2A receptor antag
onist, MDL 100,907, blocked excitation of these interneurons by 5-HT,
LSD and DOI, but not by norepinephrine or ha-amino-3-hydroxy-5-methyl-
4-isoxazolepropionate. Again, consistent with a partial agonist action
of the hallucinogens, intracellular experiments showed that a maximal
concentration of DOI (10 mu M) induced fewer postsynaptic inhibitory
currents than did 5-HT (100 mu M) in pyramidal neurons in layer II of
the piriform cortex. Based on the present electrophysiological studies
, we conclude that LSD and DOI, a phenethylamine hallucinogen, act as
highly potent partial agonists at cortical 5-HT2A receptors.